DACOGEN

This brand name is authorized in Austria, Brazil, Cyprus, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug DACOGEN contains one active pharmaceutical ingredient (API):

1 Decitabine UNII 776B62CQ27 - DECITABINE

Decitabine is a cytidine deoxynucleoside analogue that selectively inhibits DNA methyltransferases at low doses, resulting in gene promoter hypomethylation that can result in reactivation of tumour suppressor genes, induction of cellular differentiation or cellular senescence followed by programmed cell death. Read about Decitabine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DACOGEN Powder for concentrate for solution for infusion	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC08	Decitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514507501170311
Country: EE	Ravimiamet	Identifier(s): 1595583
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 112792001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 146466
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 215216
Country: HK	Department of Health Drug Office	Identifier(s): 63484, 67129
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6562
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1067906
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 103764
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100289486
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W59587001
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699593775048
Country: US	FDA, National Drug Code	Identifier(s): 59148-046
Country: ZA	Health Products Regulatory Authority	Identifier(s): 46/26/0608